Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diaceutics (GB:DXRX)
LSE:DXRX
Holding GB:DXRX?
Track your performance easily
DXRX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range84.50p - 136.00p
Previous Close125.5p
Volume57.80K
Average Volume (3M)82.82K
Market Cap
£106.02M
Enterprise Value87.50M
Total Cash (Recent Filing)£19.84M
Total Debt (Recent Filing)£1.33M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Mar 25, 2025EPS Estimate
£0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding84,773,888
10 Day Avg. Volume189,493
30 Day Avg. Volume82,819
Standard Deviation0.14
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)261.46
Price to Sales (P/S)4.86
Price to Cash Flow (P/CF)76.20
P/FCF Ratio71.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
173.74pPrice Target Upside38.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Diaceutics News
PremiumCompany Announcements
Diaceutics PLC Announces Major Shareholding Change
PremiumCompany Announcements
Diaceutics PLC Sees Change in Major Holdings
PremiumCompany Announcements
Diaceutics Secures $5.1M Contract to Enhance Cancer Treatment
PremiumCompany Announcements
Diaceutics Secures £1M UK Grant for Precision Medicine
PremiumCompany Announcements
Diaceutics Aligns Executive Interests with Shareholders
PremiumCompany Announcements
Diaceutics Expands US Market with New PartnershipsPremiumCompany Announcements
Diaceutics Expands US Market Reach with New Partnerships
PremiumCompany Announcements
Diaceutics Hosts Webinar on Precision Medicine InnovationOptions Prices
Currently, No data available
---
Ownership Overview
DXRX FAQ
What was Diaceutics’s price range in the past 12 months?
Diaceutics lowest share price was 84.50p and its highest was 136.00p in the past 12 months.
What is Diaceutics’s market cap?
Currently, no data Available
When is Diaceutics’s upcoming earnings report date?
Diaceutics’s upcoming earnings report date is Mar 25, 2025 which is in 92 days.
How were Diaceutics’s earnings last quarter?
Diaceutics released its earnings results on Sep 17, 2024. The company reported -0.031p earnings per share for the quarter, beating the consensus estimate of -0.038p by 0.007p.
Is Diaceutics overvalued?
According to Wall Street analysts Diaceutics’s price is currently Undervalued.
Does Diaceutics pay dividends?
Diaceutics does not currently pay dividends.
What is Diaceutics’s EPS estimate?
Diaceutics’s EPS estimate is £0.02.
How many shares outstanding does Diaceutics have?
Diaceutics has 84,773,890 shares outstanding.
What happened to Diaceutics’s price movement after its last earnings report?
Diaceutics reported an EPS of -0.031p in its last earnings report, beating expectations of -0.038p. Following the earnings report the stock price went up 3.922%.
Which hedge fund is a major shareholder of Diaceutics?
Currently, no hedge funds are holding shares in GB:DXRX
---
Diaceutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
173.74p (38.44% Upside)
173.74p (38.44% Upside)
Blogger Sentiment
Bullish
GB:DXRX Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-7.11%
Trailing 12-Months
Asset Growth
-2.07%
Trailing 12-Months
Company Description
Diaceutics
Diaceutics PLC is a data analytics and implementation services company that services the global pharmaceutical industry. The company's data analytics services, including Landscape, Tracking and Primary Market Research, leverage the diagnostic testing information to provide data-driven insights to drive seamless integration of diagnostic tests into treatment pathways.
---
DXRX Company Deck
---
DXRX Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a mix of positive developments, particularly with revenue growth, high gross margins, and the strategic launch of the PMx solution, alongside record order book figures. However, challenges such as the increased EBITDA loss and decreased TCV were noted. The overall sentiment leans towards optimism, driven by strategic advancements and strong financial positioning.Read More>---
DXRX Stock 12 Month Forecast
Average Price Target
173.74p
▲(38.44% Upside)
Technical Analysis
Best Analysts Covering DXRX
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
+6.02%
reiterated a buy rating 3 months ago
Copying Christian Glennie's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of +6.02% per trade.
---